Themes

Cancer and Blood Diseases

The Monash Partners Comprehensive Cancer Consortium (MPCCC) is the Cancer and Blood Diseases Theme. MPCCC is a strategic alliance of health service and research organisations working in partnership to improve outcomes for people affected by cancer. Our partners work collaboratively to bring a coordinated, multidisciplinary approach to innovating clinical oncology practices, improving cancer services and delivering the next generation of research for better cancer prevention, early detection and treatment of cancer.

Our goal is to improve patient experience and outcomes across the cancer care continuum, through world-class research and quality improvement.

This ambition will be realised by linking our expertise across basic translational, clinical, health service, population health and epidemiological research with the service delivery expertise of our clinical partners.

You can find out more about Monash Partners Comprehensive Cancer Consortium work here or follow MPCCC on Twitter and LinkedIn .

News and Resources

Supporting a state-wide plan for insatiable hunger Monash Partners is delighted to support the Prader-Willi Syndrome Association of Victoria in their 15 for 15 Challenge running 17 to 31… more
Improving the diagnosis of heart valve disease Research into improving ultrasound machines to provide more accurate diagnosis on heart valve replacement has been awarded $50,000 in Seed… more
Recognition of our future women scientists and engineers A new initiative led by our clinical innovation platform, Monash University's Monash Institute of Medical Engineering, is inspiring women scientists… more
MRFF Rapid Applied Research Translation Grant Program, opportunity to submit EOI Monash Partners will be leading the coordinated single Monash University administered bid for the RART grant round 2021. Here we… more

View all News & Resources